Recently, more and more works have identified the potential of FSTL1 as a tumor suppressor because of its ability to negatively regulate the motility and invasion of ovarian (9), renal (10), lung (11), and nasopharyngeal cancer cells (12). This evidence concerns the gene FSTL1 and neoplasm.